Effect of Fermented Soy Based Product on Cardiometabolic Risk Factors
Last updated on July 2021Recruitment
- Recruitment Status
- Completed
- Estimated Enrollment
- 31
Summary
- Conditions
- Cardiovascular Risk Factor
- Heart Diseases
- Inflammation
- Type
- Interventional
- Phase
- Not Applicable
- Design
- Allocation: RandomizedIntervention Model: Crossover AssignmentIntervention Model Description: This dietary intervention trial is a randomized, 2x2 crossover design with 24 subjects in free-living conditions.There will be a two week run-in (acclimation period), after which subjects will be randomized to receive either Q CAN powder or placebo powder for 12 weeks. Following a two week wash out period, subjects will be switched over to the alternate treatment.Masking: Double (Participant, Investigator)Masking Description: Both the participants and the investigators will not be aware of which powder is the active powder and which one is the placebo. Only the Principle Investigator will be made aware.Primary Purpose: Prevention
Participation Requirements
- Age
- Between 29 years and 75 years
- Gender
- Both males and females
Description
The purpose of this research study is to investigate the effects of a dietary supplement from soybeans that might help in managing heart disease. The rationale for this study is to reduce the risk factors of heart disease in high risk individuals by using soy supplements. The dietary supplement inte...
The purpose of this research study is to investigate the effects of a dietary supplement from soybeans that might help in managing heart disease. The rationale for this study is to reduce the risk factors of heart disease in high risk individuals by using soy supplements. The dietary supplement intervention trial is a randomized, 2x2 cross over design with 24 subjects in free-living conditions. There will be a two week run-in (acclimation period) after which subjects will be randomized to receive either QCAN powder or placebo powder for 12 weeks. Following a two week wash out period, subjects will be switched over(cross over) to alternate treatment. Thus, the interventions of the study will last for a total of 28 weeks.
Tracking Information
- NCT #
- NCT03429920
- Collaborators
- Not Provided
- Investigators
- Principal Investigator: Joan Sabate, DrPH Loma Linda University
Get Well Soon